Membrane binding of oligomeric α-synuclein depends on bilayer charge and packing

FEBS Letters

Volumn 582, Issue 27, 2008, Pages 3788-3792

  van Rooijen, Bart D ^a   Claessens, Mireille M A E ^a   Subramaniam, Vinod ^a  

^a UNIVERSITY OF TWENTE   (Netherlands)

Author keywords

Amyloid; Confocal fluorescence microscopy; Lipid; Parkinson's disease; Pore; Synuclein

Indexed keywords

ALPHA SYNUCLEIN; OLIGOMER;

ARTICLE; BILAYER MEMBRANE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; FLUORESCENCE MICROSCOPY; LIPID COMPOSITION; MEMBRANE BINDING; MEMBRANE DAMAGE; MEMBRANE PERMEABILITY; NONHUMAN; PRIORITY JOURNAL;

ALPHA-SYNUCLEIN; LIPID BILAYERS; MICROSCOPY, CONFOCAL; MICROSCOPY, FLUORESCENCE; PARKINSON DISEASE; PERMEABILITY;

EID: 54849417407     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2008.10.009     Document Type: Article

References (28)

1. Clayton D.F., and George J.M. The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration and disease. Trends Neurosci. 21 (1998) 249-254
2. Spillantini M.G., Schmidt M.L., Lee V.M., Trojanowski J.Q., Jakes R., and Goedert M. Alpha-synuclein in Lewy bodies. Nature 388 (1997) 839-840
3. Zarranz J.J., et al. The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia. Ann. Neurol. 55 (2004) 164-173
4. Krüger R., et al. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat. Genet. 18 (1998) 106-108
5. Polymeropoulos M.H., et al. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 276 (1997) 2045-2047
6. Weinreb P.H., Zhen W., Poon A.W., Conway K.A., and Lansbury Jr. P.T. NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded. Biochemistry 35 (1996) 13709-13715
7. Tofaris G.K., and Spillantini M.G. Physiological and pathological properties of alpha-synuclein. Cell Mol. Life Sci. 64 (2007) 2194-2201
8. Conway K.A., Harper J.D., and Lansbury Jr. P.T. Fibrils formed in vitro from alpha-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid. Biochemistry 39 (2000) 2552-2563
9. Davidson W.S., Jonas A., Clayton D.F., and George J.M. Stabilization of alpha-synuclein secondary structure upon binding to synthetic membranes. J. Biol. Chem. 273 (1998) 9443-9449
10. Stöckl M., Fischer P., Wanker E., and Herrmann A. Alpha-synuclein selectively binds to anionic phospholipids embedded in liquid-disordered domains. J. Mol. Biol. 375 (2008) 1394-1404
11. Rhoades E., Ramlall T.F., Webb W.W., and Eliezer D. Quantification of alpha-synuclein binding to lipid vesicles using fluorescence correlation spectroscopy. Biophys. J. 90 (2006) 4692-4700
12. Eliezer D., Kutluay E., Bussell Jr. R., and Browne G. Conformational properties of alpha-synuclein in its free and lipid-associated states. J. Mol. Biol. 307 (2001) 1061-1073
13. Lee H.J., Choi C., and Lee S.J. Membrane-bound alpha-synuclein has a high aggregation propensity and the ability to seed the aggregation of the cytosolic form. J. Biol. Chem. 277 (2002) 671-678
14. Lashuel H.A., Hartley D., Petre B.M., Walz T., and Lansbury Jr. P.T. Neurodegenerative disease: amyloid pores from pathogenic mutations. Nature 418 (2002) 291
15. Goldberg M.S., and Lansbury Jr. P.T. Is there a cause-and-effect relationship between alpha-synuclein fibrillization and Parkinson's disease?. Nat. Cell Biol. 2 (2000) E115-E119
16. Volles M.J., and Lansbury Jr. P.T. Relationships between the sequence of alpha-synuclein and its membrane affinity, fibrillization propensity, and yeast toxicity. J. Mol. Biol. 366 (2007) 1510-1522
17. Kayed R., Head E., Thompson J.L., McIntire T.M., Milton S.C., Cotman C.W., and Glabe C.G. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300 (2003) 486-489
18. Lashuel H.A., and Lansbury Jr. P.T. Are amyloid diseases caused by protein aggregates that mimic bacterial pore-forming toxins?. Quart. Rev. Biophys. 39 (2006) 167-201
19. Quist A., et al. Amyloid ion channels: a common structural link for protein-misfolding disease. Proc. Natl. Acad. Sci. USA 102 (2005) 10427-10432
20. Volles M.J., and Lansbury Jr. P.T. Vesicle permeabilization by protofibrillar alpha-synuclein is sensitive to Parkinson's disease-linked mutations and occurs by a pore-like mechanism. Biochemistry 41 (2002) 4595-4602
21. Volles M.J., Lee S.J., Rochet J.C., Shtilerman M.D., Ding T.T., Kessler J.C., and Lansbury Jr. P.T. Vesicle permeabilization by protofibrillar alpha-synuclein: implications for the pathogenesis and treatment of Parkinson's disease. Biochemistry 40 (2001) 7812-7819
22. van Raaij M.E., Segers-Nolten I.M., and Subramaniam V. Quantitative morphological analysis reveals ultrastructural diversity of amyloid fibrils from alpha-synuclein mutants. Biophys. J. 91 (2006) L96-L98
23. Angelova N., Soleau S., Meleard P., Faucon J.F., and Bothorel P. Preperation of giant vesicles by external AC electric fields. Kinetics and applications. Prog. Colloid Polym. Sci. 89 (1992) 127-131
24. Chen P.S., Toribara T.Y., and Warner H. Microdetermination of phosphorus. Anal. Chem. 28 (1956) 1756-1758
25. Mouritsen O.G., and Zuckermann M.J. What's so special about cholesterol?. Lipids 39 (2004) 1101-1113
26. Baumgart T., Hess S.T., and Webb W.W. Imaging coexisting fluid domains in biomembrane models coupling curvature and line tension. Nature 425 (2003) 821-824
27. Smith D.P., Tew D.J., Hill A.F., Bottomley S.P., Masters C.L., Barnham K.J., and Cappai R. Formation of a high affinity lipid-binding intermediate during the early aggregation phase of alpha-synuclein. Biochemistry 47 (2008) 1425-1434
28. Kayed R., Sokolov Y., Edmonds B., McIntire T.M., Milton S.C., Hall J.E., and Glabe C.G. Permeabilization of lipid bilayers is a common conformation-dependent activity of soluble amyloid oligomers in protein-misfolding diseases. J. Biol. Chem. 279 (2004) 46363-46366